Showing results (1821-1830 of 1,972) with videos related to

Sort By:
Pageof 198
Cancer Research|September 15, 2017
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck CancerBenjamin A Kansy, Fernando Concha-Benavente, Raghvendra M Srivastava, et al.
Cardiovascular and Interventional Radiology|August 20, 2017
Electromagnetically Navigated In Situ Fenestration of Aortic Stent Grafts: Pilot Animal Study of a Novel Fenestrated EVAR ApproachTobias Penzkofer, Hong-Sik Na, Peter Isfort, et al.
The Journal of Physical Chemistry. B|November 17, 2025
The Butterfly Structure of Leucomethylene Blue Results in Weak Binding to Single- or Double-Stranded DNARobert H Batchelor, Yunus A Kaiyum, Emily Hoi Pui Chao, et al.
Cancer Research|October 19, 2007
Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunityYutaro Nakamura, Payal Watchmaker, Julie Urban, et al.
Oral Oncology|October 29, 2021
Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavityJoaquin E Jimenez, Marci Lee Nilsen, William E Gooding, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 22, 2025
How the Arrangement of Platinum Atoms on Ruthenium Nanoparticles Improves Hydrogen Evolution ActivityQinyu Li, Soshan Cheong, Agus R Poerwoprajitno, et al.
Angewandte Chemie (International Ed. in English)|June 14, 2018
Three-Dimensional Branched and Faceted Gold-Ruthenium Nanoparticles: Using Nanostructure to Improve Stability in Oxygen Evolution ElectrocatalysisLucy Gloag, Tania M Benedetti, Soshan Cheong, et al.
The British Journal of Radiology|May 17, 2026
A multi-centre real-world evaluation of AI-assisted organ at risk contouring on radiotherapy treatment planning workflowsC Inverarity, B Caswell-Midwinter, B Jamshidi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancerAthanassios Argiris, Dwight E Heron, Ryan P Smith, et al.
Pageof 198